Bioventus, Inc. Class A BVS 深 沪
等待开盘 04-02 09:30:00 美东时间
9.15
+0.020
+0.22%
华盛通- 最 高9.36
- 今 开9.19
- 成交量 33.15万股
- 最 低 9.08
- 昨 收 9.13
- 总市值 7.61亿
- 52周最高 9.53
- 市盈率 静 27.74
- 换手率 0.40%
- 52周最低 5.81
- 委 比 -44.01%
- 总股本 8315.48万
- 历史最高 19.941
- 量 比 0.64
- 振 幅 3.07%
- 历史最低 0.7999
- 每 手 1
- 风险率 0.77%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅183%！迈威尔科技获10家机构上调目标价最高至164美元；伯灵顿百货、好市多、Ciena、Samsara等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持BridgeBio Oncology"买入"评级，目标价从27美元升至29美元；韦德布什：维持WAVE Life Sciences"跑赢大市"评级，目标价从33美元升至35美元
03-09 11:47
Craig-Hallum Maintains Buy on Bioventus, Raises Price Target to $16
Craig-Hallum analyst Alexander Nowak maintains Bioventus (NASDAQ:BVS) with a Buy and raises the price target from $15 to $16.
03-07 02:03
BUZZ-U.S. STOCKS ON THE MOVE -Burlington Stores, Berkshire Hathaway, Bioventus
BUZZ-U.S. STOCKS ON THE MOVE -Burlington Stores, Berkshire Hathaway, Bioventus Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were on track to open lower
03-05 22:13
BUZZ-Bioventus rises after better-than-expected quarterly results
BUZZ-Bioventus rises after better-than-expected quarterly results ** Shares of medical device maker Bioventus BVS.O rise 7.58% to $9.11 premarket ** Co posts Q4 adjusted profit of 24 cents per share vs analysts' estimate of 22 cents per share, according to data compiled by LSEG ** Posts Q4 net sales
03-05 21:45
Bioventus Q4 Earnings Assessment
Bioventus (NASDAQ:BVS) announced its Q4 earnings on Thursday, March 5, 2026 at ...
03-05 20:10
Bioventus beats Q4 revenue estimates on strong demand for pain treatments and surgical solutions
Bioventus beats Q4 revenue estimates on strong demand for pain treatments and surgical solutions Overview Medical device firm's Q4 revenue rose 2.8%, beating analyst expectations Adjusted EPS for Q4 beat analyst expectations Company generated $38 mln in Q4 cash from operations, up 97% yr/yr Outlook
03-05 20:09
Bioventus Earnings Report: Q4 Overview
The earnings results for Bioventus (NASDAQ:BVS) for Q4 were made public on Thur...
03-05 20:04
Bioventus Sees FY2026 Adj EPS $0.73-$0.77 vs $0.77 Est; Sees Sales $600.000M-$610.000M vs $604.182M Est
2026 Financial Guidance Bioventus introduced its financial guidance for full-year 2026. The Company expects: Net sales of $600 million to $610 million. This reflects growth of approximately 6% to 7%.Adjusted
03-05 20:03
Bioventus Q4 cash from operations jumps 97% to USD 38 million
Bioventus Q4 cash from operations jumps 97% to USD 38 million Bioventus reported Q4 2025 revenue of USD 157.9 million, up 2.8%, and GAAP diluted EPS of USD 0.21. Q4 net income attributable to shareholders was USD 14.8 million, while adjusted EBITDA was USD 36.7 million (up 30%) and cash from operati
03-05 20:03
BRIEF-Bioventus Q4 Adjusted EPS USD 0.24
BRIEF-Bioventus Q4 Adjusted EPS USD 0.24 Mar 05 (Reuters) - Bioventus Q4 sales USD 157.9 million vs. IBES estimate USD 154.8 million. Q4 adjusted EBITDA USD 36.7 million
03-05 20:00
